PCN188 - ASSESSING THE ROBUSTNESS OF A COST-EFFECTIVENESS ANALYSIS OF LENVATINIB VERSUS SORAFENIB IN UNRESECTABLE HEPATOCELLULAR CARCINOMA IN JAPAN

Abstract

Authors

S. Ikeda M. Kudo N. Izumi S. Kaneko M. Kobayashi M. Azuma R. Copher S. Virabhak D. Mitchell G. Meier M. Ishii